Specifically, TrkA (NTRK1) and C (NTRK3) expression are associated with favorable outcomes in neuroblastoma, while TrkB (NTRK2) is associated with biologically aggressive disease [20]. This evidence concerns the gene NTRK3 and neuroblastoma.